在急性冠状动脉综合征患者的非罪祸首病变中结结
Xi Wu1, Mingxing Wu1, Haobo Huang1
1Department of Cardiology, Xiangtan Central Hospital, 411100 Xiangtan, Hunan, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
在非罪祸首的病变中结结 (CN) 在急性冠状动脉综合征 (ACS) 患者中很常见. 这些发现表明,与以前的看法相反,非罪祸首病变中的CN与更好的临床结果有关.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管生物学 血管生物学
背景情况:
- 在非罪祸首的病变中结结 (CN) 在急性冠状动脉综合征 (ACS) 中没有得到充分研究.
- 以前的研究将CN与不良结果联系起来,但关于ACS中非罪祸首病变的数据很少.
- 了解非罪祸首病变中的CN对于ACS风险分层和治疗策略至关重要.
研究的目的:
- 确定ACS患者非致病病变中的结结 (CN) 的频率,分布,预测因素和临床结果.
- 调查非罪祸首病变和主要不良心血管事件 (MACE) 中的CN之间的关联.
- 在ACS的背景下,提供有关CN的预后意义的见解.
主要方法:
- 对376名ACS患者进行了回顾性分析,其中376名ACS患者成功进行了致病病变支架.
- 血管内超声波 (IVUS) 用于评估左主动脉和冠状动脉中非罪祸首的病变.
- 标记符号的定义:小的,凸起的,结状的沉积物突出进入光线.
主要成果:
- 在16.9%的动脉和26.9%的患者中发现了结节 (CN).
- 主要位于右中冠状动脉和分叉部位的CN.
- 患有CN的患者年龄较大,糖尿病患病率较高;然而,CN与后倾向性得分匹配 (PSM) 后的MACE率明显较低有关.
结论:
- 在ACS患者的非罪祸首病变中,结结 (CN) 很普遍.
- 非罪祸首病变中的CN与较低的重大心血管不良事件 (MACE) 发病率有关.
- 这些发现挑战了先前的假设,并强调了CN在ACS中非罪祸首病变中的潜在保护作用.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.2K
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
15.7K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
128
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Imaging Studies for Cardiovascular System III: X-Ray
164
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
164
